Clinics I work with
My reviews
Selected research
-
Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab.
The British journal of ophthalmology
-
Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study.
Eye (London, England)
-
Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients.
Eye (London, England)
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-2020
4.5